A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Recruiting now · Not applicable

Conditions studied: Aortic Aneurysm, Aortic Aneurysm and Dissection, Aortic Diseases, Aneurysm of Aorta, Thoracic, Aneurysmal Disease, Aorta, Thoracic Pathologies

In brief

The Goal of this Clinical Study is to evaluate the safety and effectiveness of the Rapidlink device in the repair or replacement of the supra-aortic vessels during open surgical repair of aortic disease affecting the thoracic aorta. This study will collect information on patients who are already having surgery to repair their aorta and who will have Rapidlink device implanted into one or more of the aortic arch vessels. The first 32 subjects enrolled will undergo left subclavian artery repair or replacement, only, with the Rapidlink device. After the 32nd subject, enrollment will proceed to include subjects undergoing any supra-aortic vessel (i.e., left subclavian artery, left common carotid artery, and/or innominate artery) repair or replacement with the Rapidlink device in a planned surgery. After the 32nd subject is enrolled in the main group, up to 30 subjects will undergo supra-aortic vessel (i.e., left subclavian artery, left common carotid artery, and/or innominate artery) repair or replacement with the Rapidlink device in an emergency setting. Data will be collected before, during and after surgery including recovery at discharge, 30 days, 6 months, 1 and 2 years after the surgery.

Key facts

Study ID: NCT07078383
Run by: Vascutek Ltd.
People needed: 150
Starts: 2025-12-19
Expected to finish: 2028-11-01
Last updated by the study team: 2026-07-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patient is aged 18 years or over on date of consent
Written informed consent (from patient or a legally authorized representative) to participate in study, documenting willingness and ability to comply with all study procedures and study visits (unless an exemption for emergency cases has been IRB / EC approved)
Patient's need for open surgical repair of the thoracic aorta using a Gelweave graft or a Thoraflex Hybrid device (AnteFlo or Plexus) in line with the applicable IFU
Anticipated need to use Rapidlink for the repair or replacement of the LSA, LCCA and/or IA during the open surgical repair
Patient has an 8-15 mm inner diameter (target SAV)
The diameters of the patient's target supra-aortic vessel(s), fall within the ranges specified in the IFU

You may not qualify if…

Patient does not have a clear landing zone equal to the implantable stent length which is free from stenosis, calcification or thrombus.
Patient does not have a sealing zone free from tortuosity.
Patient has significant angulation (>79° with an internal radius of less than 6mm) for the full implantable stent length
Patient cannot receive anticoagulation / antiplatelet therapy during or after the index procedure as per the protocol
Patient has uncontrolled hypercoagulation
Patient has a condition which may compromise or prevent the necessary imaging requirements
Patient has anatomic variants which would compromise circulation to the first branch off the target artery after placement of the Rapidlink device (unless planned and/or otherwise revascularized)
Patient is unfit for open surgical repair involving circulatory arrest per the study investigator
Patient has known sensitivity to polyester, nitinol, tantalum, or materials of bovine origin
Patient has a ruptured aorta
Patient has active endocarditis or an active infective disorder of the aorta
Patient has an active systemic infection that, in the opinion of the investigator, would compromise the outcome of the surgical procedure
Patient is enrolled in another active study and has received an investigational product (device, pharmaceutical or biologic) within 6 months prior to the date of the implant or has not reached the primary endpoint of the study
Patient is female and is pregnant or planning to become pregnant during the course of the study. Females of childbearing potential must use acceptable methods of contraception during the course of the study.
Patient has an uncorrectable bleeding anomaly
Patient has renal failure (defined as dialysis dependent or serum creatinine ≥2.5mg/dL)
Patient has known sensitivity to radiopaque contrast agents that cannot be adequately pre-treated
Patient has a co-morbidity causing expected survival to be less than 1 year
Patient has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving this treatment and the procedures and evaluations pre and post procedure
Patient has a known chronic aortic dissection involving the intended landing zone of the target supra-aortic vessel(s)

Where it is running

Froedhert Hospital — Milwaukee, Wisconsin, United States (enrolling)
Barnes-Jewish Hospital — St Louis, Missouri, United States (enrolling)
Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
Johns Hopkins Hospital — Baltimore, Maryland, United States (enrolling)
Acension Seton Medical Center — Austin, Texas, United States (enrolling)
Radboud University Medical Center — Nijmegen, Radboud, Netherlands (enrolling)
Baylor Scott & White The Heart Hospital - Plano — Plano, Texas, United States (enrolling)
Massachusetts General Hospital — Boston, Massachusetts, United States
UPMC Presbyterian — Pittsburgh, Pennsylvania, United States
University Hospital Vienna — Vienna, Austria
University Medical Center Freiburg — Freiburg im Breisgau, Germany
University Medical Center Hamburg-Eppendorf — Hamburg, Germany
Robert Bosch Hospital — Stuttgart, Germany
Keck Medicine of USC — Los Angeles, California, United States
St Bartholomew's Hospital — London, United Kingdom
Cedars-Sinai Medical Center — Los Angeles, California, United States
University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
Medstar Washington Hospital Center — Washington D.C., District of Columbia, United States
UF Health Shands Hospital — Gainesville, Florida, United States
Tampa General Hospital — Tampa, Florida, United States
Northwestern Memorial Hospital — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.